These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 5924136)

  • 1. Drug names--a semblance of order.
    Feldman EG
    J Pharm Sci; 1966 Jun; 55(6):i. PubMed ID: 5924136
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: Standardization of drug names.
    Lewis JR
    JAMA; 1974 Jul; 229(5):559-60. PubMed ID: 4406902
    [No Abstract]   [Full Text] [Related]  

  • 3. When names make claims: ethical issues in medical device marketing.
    Bramstedt KA
    Ethics Med; 2004; 20(2):47-57. PubMed ID: 15468483
    [No Abstract]   [Full Text] [Related]  

  • 4. Standardization of drug names.
    Allan FM
    JAMA; 1974 Jul; 229(5):541-3. PubMed ID: 4406898
    [No Abstract]   [Full Text] [Related]  

  • 5. New names for drugs: what is USAN?
    Andrako J
    JAMA; 1977 May; 237(22):2413-4. PubMed ID: 576948
    [No Abstract]   [Full Text] [Related]  

  • 6. New drugs: the AMA and the FDA.
    Appel JZ
    Ann Allergy; 1966 Jul; 24(7):333-6. PubMed ID: 5941864
    [No Abstract]   [Full Text] [Related]  

  • 7. New drugs: the AMA and FDA roles.
    Appel JZ
    J Ark Med Soc; 1966 Jul; 63(2):67-9. PubMed ID: 4223555
    [No Abstract]   [Full Text] [Related]  

  • 8. Some thoughts on the generic equivalency debate.
    Berry FB
    Med Times; 1971 Sep; 99(9):199-201. PubMed ID: 5170858
    [No Abstract]   [Full Text] [Related]  

  • 9. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
    Daemmrich A
    Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
    [No Abstract]   [Full Text] [Related]  

  • 10. USAN and FDA.
    Am J Pharm Sci Support Public Health; 1966; 138(5):172-4. PubMed ID: 5976320
    [No Abstract]   [Full Text] [Related]  

  • 11. Procedure for evaluation of new drugs.
    Weston JK
    J New Drugs; 1965; 5(5):294-6. PubMed ID: 5887954
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs, codes, standards, and other incompatible things in the dark.
    Chute CG
    MD Comput; 2001; 18(1):45-6. PubMed ID: 11236386
    [No Abstract]   [Full Text] [Related]  

  • 13. Two new efforts to inform patients about drugs launch a post-PPI era.
    Med World News; 1982 Sep; 23(20):8-9. PubMed ID: 11645760
    [No Abstract]   [Full Text] [Related]  

  • 14. Animal models in biomedical research: some epistemological worries.
    LaFollette H; Shanks N
    Public Aff Q; 1993 Apr; 7(2):113-30. PubMed ID: 11652915
    [No Abstract]   [Full Text] [Related]  

  • 15. Change in FDA definition of serious adverse drug event.
    Bader RL
    Am J Hosp Pharm; 1989 Jun; 46(6):1132. PubMed ID: 2750762
    [No Abstract]   [Full Text] [Related]  

  • 16. Worries about animal models in biomedical research: a response to LaFollette and Shanks.
    Willis LR; Hulsey MG
    Public Aff Q; 1994 Apr; 8(2):205-18. PubMed ID: 11652920
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacopeia and preparations for cutaneous application].
    Esnault F; Etchegaray JP; Mallard C
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714
    [No Abstract]   [Full Text] [Related]  

  • 18. Dermatologic look- or sound-alike medications.
    Gremillion L; Hogan DJ
    J Drugs Dermatol; 2004; 3(1):61-4. PubMed ID: 14964748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. List no. 92. New names.
    JAMA; 1970 Aug; 213(8):1325-6. PubMed ID: 4914748
    [No Abstract]   [Full Text] [Related]  

  • 20. Council on drugs. List No. 95. New names.
    JAMA; 1970 Nov; 214(9):1693. PubMed ID: 5536533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.